Taro Corporate
Taro U.S.A
Taro Canada
Taro Israel
Sun Pharma
Chattem Chemicals Inc.
Taro RX product details
Product Information
-
DIN:02511304
-
Active Ingredients :Tofacitinib citrate
-
Innovator Name:XELJANZ®
-
Dosage form:Tablets
-
Strength:5 mg
-
Route of Administration:Oral
- Package size:
60 Bottle 180 Bottle - UPC Code:
063691101555 063691101579 -
Non-medicinal ingredients :Croscarmellose sodium, FD&C Blue#1 (in 10 mg tablets only), FD&C Blue#2 (in 10 mg tablets only), hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, titanium dioxide and triacetin
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here
Product Information
-
DIN:02511312
-
Active Ingredients :Tofacitinib citrate
-
Innovator Name:XELJANZ®
-
Dosage form:Tablets
-
Strength:10 mg
-
Route of Administration:Oral
- Package size:
60 Bottle - UPC Code:
063691101593 -
Non-medicinal ingredients :Croscarmellose sodium, FD&C Blue#1 (in 10 mg tablets only), FD&C Blue#2 (in 10 mg tablets only), hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, titanium dioxide and triacetin
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here